(Q46859906)

English

Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy?

scientific article published on 7 December 2007

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Should prophylactic granulocyte-colony stimulating factor be used in multiple myeloma patients developing neutropenia under lenalidomide-based therapy? (English)

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Ramón García-Sanz

2

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

Jesús San Miguel

5

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

María Victoria Mateos

1

object named as

María-Victoria Mateos

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

author name string

Juan Olazábal

4

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

language of work or name

0 references

publication date

7 December 2007

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

British Journal of Haematology

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

140

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

3

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

324-326

1 reference

Europe PubMed Central

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:18067473%20AND%20SRC:MED&resulttype=core&format=json

29 December 2019

EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

Criteria for evaluating disease response and progression in patients with multiple myeloma treated by high-dose therapy and haemopoietic stem cell transplantation. Myeloma Subcommittee of the EBMT. European Group for Blood and Marrow Transplant

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

Granulocyte colony-stimulating factor enhances bone tumor growth in mice in an osteoclast-dependent manner

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

Lenalidomide: the emerging role of a novel targeted agent in malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

The evolving role of lenalidomide in the treatment of hematologic malignancies

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

Immunomodulatory drug CC-5013 overcomes drug resistance and is well tolerated in patients with relapsed multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

A randomized phase 2 study of lenalidomide therapy for patients with relapsed or relapsed and refractory multiple myeloma

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

Granulocyte-colony stimulating factor administration to healthy individuals and persons with chronic neutropenia or cancer: an overview of safety considerations from the Research on Adverse Drug Events and Reports project.

1 reference

https://api.crossref.org/works/10.1111%2FJ.1365-2141.2007.06946.X

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q46859906&oldid=1858319552"